ABCL earnings call for the period ending December 31, 2023.
Healthcare stocks have underperformed in 2023, but that is expected to change this year.
These innovation-oriented companies could take flight this year.
ABCL earnings call for the period ending September 30, 2023.
Argenx's chart is forming a bullish base after a 28% jump after positive clinical trials. Analysts believe the immunology specialist is an acquisition target.
ABCL earnings call for the period ending June 30, 2023.
ABCL earnings call for the period ending March 31, 2023.
AbCellera Biologics Inc. (ABCL) delivered earnings and revenue surprises of -16.67% and 6.76%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?...
AbCellera (Nasdaq: ABCL) today announced financial results for the first quarter of 2023. All financial information in this press release is reported in U.S. dollars, unless otherwise indicated.